Evidence map›Paper›PMID 26487786›Full record

ArticleDiabetes2016

Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds.

Stephen R Thom, Michelle Hampton, Michael A Troiano, Ziad Mirza, D Scot Malay, Steven Shannon, Nathan B Jennato, Cornelius M Donohue, Ole Hoffstad, Diana Woltereck and 5 more

Abstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Inert Gas Mild Pressure Action on Healthy Humans: The "IPA" Study.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Circulating endothelial precursor cells are associated with a healed diabetic foot ulcer evaluated in a prospective cohort study.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2023
    Article
  10. Article
  11. Further evidence that wound size and duration are strong prognostic markers of diabetic foot ulcer healing.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2022
    Article
  12. Advances in the Sensing and Treatment of Wound Biofilms.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2022
    Review
  13. Advances in the Sensing and Treatment of Wound Biofilms.Angewandte Chemie (International ed. in English) · 2022
    Review
  14. Diabetic Wound-Healing Science.Medicina (Kaunas, Lithuania) · 2021
    Review
  15. Article
  16. Review
  17. Hydrogel Dressings for Chronic Wound Healing in Diabetes: Beyond Hydration.Journal of pharmaceutics & drug delivery research · 2021
    Article
  18. Skin Microbiota and its Interplay with Wound Healing.American journal of clinical dermatology · 2020
    Review
  19. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2019
    Article
  20. Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Stephen R ThomDepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD sthom@smail.umaryland.edu.
Michelle HamptonDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Michael A TroianoPodiatric Surgery and Medicine, Penn Presbyterian Medical Center, Philadelphia, PA.
Ziad MirzaDepartment of Medicine, Greater Baltimore Medical Center, Baltimore, MD.
D Scot MalayPodiatric Surgery and Medicine, Penn Presbyterian Medical Center, Philadelphia, PA.
Steven ShannonPodiatric Surgery and Medicine, Penn Presbyterian Medical Center, Philadelphia, PA.
Nathan B JennatoPodiatric Surgery and Medicine, Penn Presbyterian Medical Center, Philadelphia, PA.
Cornelius M DonohuePodiatric Surgery, Roxborough Memorial Hospital, Philadelphia, PA.
Ole HoffstadDepartment of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Diana WoltereckDepartment of Medicine, Greater Baltimore Medical Center, Baltimore, MD.
Ming YangDepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD.
Kevin YuDepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD.
Veena M BhopaleDepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD.
Svitlana KovtunDepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD.
David J MargolisDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Funding

Stem cell mobilization and diabetic skin ulcersR01DK094260 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MARGOLIS, DAVID, THOM, STEPHEN RAYMOND · 2012 to 2016
$2.7M
NIDDK NIH HHS R01 DK094260NIDDK NIH HHS R01-DK-094260
6 · The paper itself

Abstract

Management of neuropathic foot ulcers in patients with diabetes (DFUs) has changed little over the past decade, and there is currently no objective method to gauge probability of successful healing. We hypothesized that studies of stem/progenitor cells (SPCs) in the early weeks of standard wound management could predict who will heal within 16 weeks. Blood and debrided wound margins were collected for 8 weeks from 100 patients undergoing weekly evaluations and treatment. SPC number and intracellular content of hypoxia-inducible factors (HIFs) were evaluated by flow cytometry and immunohistochemistry. More SPCs entered the bloodstream in the first 2 weeks of care in patients who healed (n = 37) than in those who did not (n = 63). Logistic regression demonstrated that the number of blood-borne SPCs and the cellular content of HIFs at study entry and the first-week follow-up visit predicted healing. Strong correlations were found among week-to-week assessments of blood-borne SPC HIF factors. We conclude that assays of SPCs during the first weeks of care in patients with DFUs can provide insight into how well wounds will respond and may aid with decisions on the use of adjunctive measures.

Indexed as

Adult Stem CellsWound HealingAntigens, CD34Diabetic FootDiabetic NeuropathiesFemaleFlow CytometryHumansLeukocyte Common AntigensLogistic ModelsMaleMiddle AgedPredictive Value of TestsTime FactorsAntigens, CD34Leukocyte Common Antigens

Identifiers

PMID26487786
PMCPMC4747459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.